Artery is pleased to announce that three abstracts containing new CS6253 data will be presented at Society for Neuroscience annual meeting (SfN2018) in San Diego.
2018-11-03 · Artery Therapeutics, Inc. · original arterytx.com ↗
Artery is pleased to announce that three abstracts containing new CS6253 data will be presented at Society for Neuroscience annual meeting (SfN2018) in San Diego. 1. Poster presentation by Dr. Ana Valencia from UIC. Title: ABCA1 activation in the CNS as a therapeutic target for APOE4-induced Alzheimer’s disease risk Session: Alzheimer's Disease and Other Dementias: Therapeutic Strategies: Preclinical Animal Models III Room: SDCC Halls B-H Date: November 6th Time: 8AM - 12PM Poster number: 468.14 / J3 2. Oral Presentation by Dr. Hussein Yassine from USC. Title: New paradigms in treating apoE4-associated Alzheimer’s disease; Proof of concept and translational finding from studies with the ABCA1 agonist therapeutic CS6253 Session: Alzheimer's Disease and Other Dementias: ApoE and Associated Pathways Room: SDCC 24 Date: November 6th Time: 1:30 PM - 1:45 PM 3. Oral Presentation by Dr. Varun Rawat, from Dr. Yassine's Lab at USC. Title: ApoE4 aggregation and hypolipidation is implicated in Alzheimer’s disease pathology in cellular, animal and human studies Session: Neurotoxicity, Inflammation, and Neuroprotection: Neuroinflammation: Neurodegeneration Room: SDCC 24 Date: November 7th Time: 10:00 AM - 10:15 AM
The release as fetched from its publisher. arterytx.com ↗